Human Papillomavirus Testing in the Prevention of Cervical Cancer
Mark Schiffman(National Institutes of Health), Philip E. Castle(National Cancer Institute)
Cited by 767
Related Papers
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
|JNCI Journal of the National Cancer Institute|2013|997
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
|Infectious Agents and Cancer|2009|457